Masteron-P (Drostanolone propionate) 100mg/ml(10ml)

Masteron Propionate (Drostanolone Propionate)

Masteron Propionate is the trade name commonly associated with drostanolone propionate, a dihydrotestosterone (DHT)-derived anabolic–androgenic steroid. It was first developed in the late 1950s and later introduced for medical use in the treatment of certain types of breast cancer, particularly due to its anti-estrogenic properties.

As a propionate ester, drostanolone propionate is considered a shorter-acting formulation, meaning it is absorbed and cleared more quickly than longer esters such as enanthate. Its chemical structure prevents aromatization (conversion to estrogen), which significantly influences its physiological effects.

Historically, drostanolone was explored in clinical settings for hormone-responsive breast cancer treatment. Over time, it also became known within athletic and bodybuilding communities due to its androgenic characteristics and its lack of estrogen conversion. However, it is important to note that it is not approved for performance enhancement use.

Pharmacological Characteristics

• Base Compound: Drostanolone (DHT derivative)

• Ester: Propionate (short-acting)

• Aromatization: Does not convert to estrogen

• Activity Profile: Anabolic with strong androgenic properties

Because of its DHT origin, drostanolone has a strong affinity for androgen receptors. Its non-aromatizing nature means it does not directly increase estrogen levels, but it still carries significant androgen-related risks.

Potential Risks and Considerations

Use of drostanolone propionate may be associated with:

• Suppression of natural testosterone production

• Adverse lipid profile changes (reduced HDL, increased LDL)

• Elevated cardiovascular risk

• Androgenic side effects such as acne and accelerated hair loss

• Possible prostate-related concerns

• Hormonal imbalance

As with other anabolic steroids, long-term use may increase cardiovascular and endocrine health risks.

Masteron-E 200mg/ml(10ml)